Cetera Investment Advisers
AXSM icon

Cetera Investment Advisers’s Axsome Therapeutics AXSM Stock Holding History

Cetera Investment Advisers’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Sell
9,355
-1,364
-13% -$296K ﹤0.01% 2286
2026
Q1 		$1.81M Buy
10,719
+1,013
+10% +$175K ﹤0.01% 2370
2025
Q4 		$1.77M Buy
9,706
+38
+0.4% +$5.3K ﹤0.01% 2322
2025
Q3 		$1.17M Buy
9,668
+2,448
+34% +$276K ﹤0.01% 2642
2025
Q2 		$754K Buy
7,220
+65
+0.9% +$6.88K ﹤0.01% 2636
2025
Q1 		$834K Buy
7,155
+46
+0.6% +$5.24K ﹤0.01% 2410
2024
Q4 		$601K Buy
7,109
+1,160
+19% +$107K ﹤0.01% 2539
2024
Q3 		$535K Sell
5,949
-183
-3% -$16K ﹤0.01% 2602
2024
Q2 		$494K Buy
6,132
+457
+8% +$33.8K ﹤0.01% 2607
2024
Q1 		$453K Buy
+5,675
New +$476K ﹤0.01% 2675

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cetera Investment Advisers's AXSM Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Axsome Therapeutics (AXSM) stake by 13% in Q2 2026, selling an estimated $296K and leaving 9,355 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Cetera Investment Advisers first reported a position in AXSM in Q1 2024 and has held it in 10 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Cetera Investment Advisers held 9,355 shares of Axsome Therapeutics worth $2.29M as of Q2 2026.
  • Cetera Investment Advisers sold 1,364 Axsome Therapeutics shares in Q2 2026, an estimated $296K.
  • Axsome Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2286 holding.
  • Cetera Investment Advisers first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.